Dynatrace (DT)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$46.78-0.53%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
Research Workspace
Put DT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Application Software is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 18% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 20%.
View QualityManagement screens strong on margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 35% in its worst 12-month stretch.
View RiskDynatrace's 17% revenue growth must keep compounding to justify the price. Revenue grew 17% year over year in the latest quarter. The company also beat its earnings estimate by 92.9%. It trades at 28 times earnings versus a 28 times peer median. The price reflects less growth than we forecast. Delayed enterprise deals threaten the ARR growth objective. Peer multiples imply a price about 6% above where it trades. Our standing thesis is intact, but this read is provisional.
Trailing returns as of 2026-11-04. DT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 37 analysts currently covering DT (as of Nov 2026).
Based on 18 Wall Street analysts offering 12-month price targets for DT in the last 4 months.
Continue this research
Compare DT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| DT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Application Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put DT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Accelerate ARR growth
Analyst cites delayed deals weighing on growth outlook.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $46.78
The last 12 months of price, then the range of analyst 12-month targets from today’s $46.78.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Accelerate ARR growth
Deal delays directly hinder ARR acceleration objectives.
Advances: Accelerate ARR growth
Official guidance confirms continued ARR growth trajectory.
Threatens: Increase revenue growth
Mixed guidance directly challenges revenue growth objective.
Advances: Increase revenue growth
Strong earnings and raised guidance support revenue growth objective.
Advances: Increase revenue growth
Upgrade indicates strong demand for observability boosting revenue growth.
Advances: Increase revenue growth
Upgrade reflects positive demand outlook, supporting revenue growth.
Advances: Advance AI-powered observability platform
Acquisition enhances AI capabilities, aligning with product objectives.
